Analyst Ratings For Medical Transcription Billing (NASDAQ:MTBC)
Today, HC Wainwright initiated coverage on Medical Transcription Billing (NASDAQ:MTBC) with a Buy .
Some recent analyst ratings include
- 3/2/2018-HC Wainwright initiated coverage with a Buy rating.
Recent Insider Trading Activity For Medical Transcription Billing (NASDAQ:MTBC)
Medical Transcription Billing (NASDAQ:MTBC) has insider ownership of 53.70% and institutional ownership of 1.88%.
- On 12/1/2017 Mahmud Ul Haq, CEO, bought 30,000 with an average share price of $2.93 per share and the total transaction amounting to $87,900.00.
- On 11/6/2017 Stephen Andrew Snyder, President, sold 50,000 with an average share price of $3.18 per share and the total transaction amounting to $159,000.00.
- On 11/15/2016 Mahmud Ul Haq, CEO, bought 90,000 with an average share price of $0.97 per share and the total transaction amounting to $87,300.00.
- On 11/14/2016 Mahmud Ul Haq, CEO, bought 1,000 with an average share price of $0.90 per share and the total transaction amounting to $900.00.
- On 3/29/2016 Bill Korn, CFO, bought 5,000 with an average share price of $1.06 per share and the total transaction amounting to $5,300.00.
- On 11/30/2015 Mahmud Ul Haq, CEO, bought 20,000 with an average share price of $1.34 per share and the total transaction amounting to $26,800.00.
- On 11/30/2015 Stephen Andrew Snyder, President, bought 5,000 with an average share price of $1.33 per share and the total transaction amounting to $6,650.00.
Recent Trading Activity for Medical Transcription Billing (NASDAQ:MTBC)
Shares of Medical Transcription Billing closed the previous trading session at 3.80 up +0.13 3.52% with 60260 shares trading hands.
